← back to search

Lindsay D. Eltis

University of British Columbia · CA
Area of research
Molecular Biology · Pollution
Research interest
Research interests include Microbial bioremediation and biosurfactants, Steroid Chemistry and Biochemistry, Pharmacogenetics and Drug Metabolism, and Microbial Metabolic Engineering and Bioproduction.
h-index
67
citations
14,479
works
272
NIH funding
primary concept
email

Recent publications

Cyclic AMP-Mediated Inhibition of Cholesterol Catabolism in <i>Mycobacterium tuberculosis</i> by the Novel Drug Candidate GSK2556286
Antimicrobial Agents and Chemotherapy 2023cited by 30position: lastdoi
Bacterial contributions to delignification and lignocellulose degradation in forest soils with metagenomic and quantitative stable isotope probing
The ISME Journal 2018cited by 392position: middledoi
Novel Inhibitors of Cholesterol Degradation in Mycobacterium tuberculosis Reveal How the Bacterium’s Metabolism Is Constrained by the Intracellular Environment
PLoS Pathogens 2015cited by 272position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Brian C. VanderVen · Cornell University2 papers (2015–2023)Roland C. Wilhelm · Purdue University West Lafayette1 papers (2018–2018)Yan‐Cheng Liu · Guangxi Normal University1 papers (2015–2015)Tiansheng Wang · University of Idaho1 papers (2015–2015)Rahul Singh · Larsen & Toubro (India)1 papers (2018–2018) · 1 papers (2015–2015) · 1 papers (2023–2023) · 1 papers (2023–2023)Ruth J. Fahey · Cornell University1 papers (2015–2015) · 1 papers (2015–2015) · 1 papers (2023–2023)Wonsik Lee · Sungkyunkwan University1 papers (2015–2015)J.C. Grigg · Ithaca College1 papers (2023–2023) · 1 papers (2015–2015)William W. Mohn · University of British Columbia1 papers (2018–2018)David G. Russell · Pfizer (United States)1 papers (2015–2015)Kaley M. Wilburn · Duke University1 papers (2023–2023) · 1 papers (2015–2015) · 1 papers (2023–2023) · 1 papers (2015–2015)